Topoisomerase II and the response to antileukemic therapy

Scott H. Kaufmann; Steven D. Gore; Carole B. Miller; Richard J. Jones; Leonard A. Zwelling; Erasmus Schneider; Philip J. Burke; Judith E. Karp

doi:10.3109/10428199809068560

Topoisomerase II and the response to antileukemic therapy

Scott H. Kaufmann, Steven D. Gore, Carole B. Miller, Richard J. Jones, Leonard A. Zwelling, Erasmus Schneider, Philip J. Burke, Judith E. Karp

Oncology

Research output: Contribution to journal › Review article

25 Scopus citations

Abstract

A number of recent studies have investigated the expression of topoisomerase II in clinical leukemia specimens. Here we outline the rationale for these studies, identify potential pitfalls, summarize recent results, and discuss unanswered questions in this area.

Original language	English (US)
Pages (from-to)	217-237
Number of pages	21
Journal	Leukemia and Lymphoma
Volume	29
Issue number	3-4
DOIs	https://doi.org/10.3109/10428199809068560
State	Published - Jan 1 1998

Keywords

Antileukemic therapy
Response to therapy
Topoisomerase II

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.3109/10428199809068560

Fingerprint Dive into the research topics of 'Topoisomerase II and the response to antileukemic therapy'. Together they form a unique fingerprint.

Cite this

Kaufmann, S. H., Gore, S. D., Miller, C. B., Jones, R. J., Zwelling, L. A., Schneider, E., Burke, P. J., & Karp, J. E. (1998). Topoisomerase II and the response to antileukemic therapy. Leukemia and Lymphoma, 29(3-4), 217-237. https://doi.org/10.3109/10428199809068560

@article{bf02a291ba294a35a7745b0e415fb3c3,

title = "Topoisomerase II and the response to antileukemic therapy",

abstract = "A number of recent studies have investigated the expression of topoisomerase II in clinical leukemia specimens. Here we outline the rationale for these studies, identify potential pitfalls, summarize recent results, and discuss unanswered questions in this area.",

keywords = "Antileukemic therapy, Response to therapy, Topoisomerase II",

author = "Kaufmann, {Scott H.} and Gore, {Steven D.} and Miller, {Carole B.} and Jones, {Richard J.} and Zwelling, {Leonard A.} and Erasmus Schneider and Burke, {Philip J.} and Karp, {Judith E.}",

year = "1998",

month = jan,

day = "1",

doi = "10.3109/10428199809068560",

language = "English (US)",

volume = "29",

pages = "217--237",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Informa Healthcare",

number = "3-4",

}

TY - JOUR

T1 - Topoisomerase II and the response to antileukemic therapy

AU - Kaufmann, Scott H.

AU - Gore, Steven D.

AU - Miller, Carole B.

AU - Jones, Richard J.

AU - Zwelling, Leonard A.

AU - Schneider, Erasmus

AU - Burke, Philip J.

AU - Karp, Judith E.

PY - 1998/1/1

Y1 - 1998/1/1

N2 - A number of recent studies have investigated the expression of topoisomerase II in clinical leukemia specimens. Here we outline the rationale for these studies, identify potential pitfalls, summarize recent results, and discuss unanswered questions in this area.

AB - A number of recent studies have investigated the expression of topoisomerase II in clinical leukemia specimens. Here we outline the rationale for these studies, identify potential pitfalls, summarize recent results, and discuss unanswered questions in this area.

KW - Antileukemic therapy

KW - Response to therapy

KW - Topoisomerase II

UR - http://www.scopus.com/inward/record.url?scp=0031868497&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031868497&partnerID=8YFLogxK

U2 - 10.3109/10428199809068560

DO - 10.3109/10428199809068560

M3 - Review article

C2 - 9684921

AN - SCOPUS:0031868497

VL - 29

SP - 217

EP - 237

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 3-4

ER -